Literature DB >> 23589141

No significant association between vitamin D and nonalcoholic fatty liver disease in a Chinese population.

Lihua Li1, Lei Zhang, Shaoyi Pan, Xinhua Wu, Xueyan Yin.   

Abstract

BACKGROUND: Some research evidence from Western populations suggests that lower vitamin D is associated with the prevalence and histologically assessed severity of nonalcoholic fatty liver disease (NAFLD). AIMS: To investigate the associations of serum 25-hydroxyvitamin D [25(OH)D] concentrations and vitamin D status (deficiency <20 ng/ml; insufficiency 20-30 ng/ml; sufficiency >30 ng/ml) with the prevalence of NAFLD in study population of Chinese.
METHODS: Serum 25(OH)D, parathyroid hormone, lipids, liver enzymes, and anthropometric characteristics were measured in 1,248 subjects aged ≥ 20 years. NAFLD was diagnosed using abdominal ultrasound examination.
RESULTS: The prevalence of NAFLD was 30.3 % in the total study population, 37.9 % in the male subjects, and 20.8 % in the female subjects (P < 0.0001). Subjects with NAFLD had a significantly higher body mass index, higher levels of fasting blood glucose and liver enzymes, and a more atherogenic lipid profile. However, serum 25(OH)D concentrations were not significantly different between subjects with and without NAFLD (22.1 vs. 22.8 ng/ml, respectively; P = 0.21). In addition, a 10 ng/ml higher serum 25(OH)D concentrations [odds ratio (OR) 1.02, 95 % confidence interval (CI) 0.84-1.25, P = 0.82] or vitamin D status (vs. sufficiency: deficiency OR 0.86, 95 % CI 0.54-1.37, P = 0.52; insufficiency OR 0.96, 95 % CI 0.61-1.52, P = 0.87) were not significantly associated with the presence of NAFLD in the multivariate logistic regression analyses.
CONCLUSIONS: Serum 25(OH)D concentrations or vitamin D status were not significantly associated with the presence of NAFLD. More studies are needed to elucidate the relationship between vitamin D and the occurrence of NAFLD in Chinese.

Entities:  

Mesh:

Year:  2013        PMID: 23589141     DOI: 10.1007/s10620-013-2658-1

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  32 in total

Review 1.  Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.

Authors:  Giovanni Targher; Christopher P Day; Enzo Bonora
Journal:  N Engl J Med       Date:  2010-09-30       Impact factor: 91.245

Review 2.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

3.  Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients.

Authors:  Giovanni Targher; Lorenzo Bertolini; Felice Poli; Stefano Rodella; Luca Scala; Roberto Tessari; Luciano Zenari; Giancarlo Falezza
Journal:  Diabetes       Date:  2005-12       Impact factor: 9.461

4.  Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease.

Authors:  Giovanni Targher; Lorenzo Bertolini; Luca Scala; Massimo Cigolini; Luciano Zenari; Giancarlo Falezza; Guido Arcaro
Journal:  Nutr Metab Cardiovasc Dis       Date:  2006-08-22       Impact factor: 4.222

Review 5.  D-livering the message: the importance of vitamin D status in chronic liver disease.

Authors:  Matthew T Kitson; Stuart K Roberts
Journal:  J Hepatol       Date:  2012-05-23       Impact factor: 25.083

6.  Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus.

Authors:  Ilaria Barchetta; Simone Carotti; Giancarlo Labbadia; Umberto Vespasiani Gentilucci; Andrea Onetti Muda; Francesco Angelico; Gianfranco Silecchia; Frida Leonetti; Antonio Fraioli; Antonio Picardi; Sergio Morini; Maria Gisella Cavallo
Journal:  Hepatology       Date:  2012-12       Impact factor: 17.425

Review 7.  Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region?

Authors:  Geoffrey C Farrell
Journal:  J Gastroenterol Hepatol       Date:  2003-02       Impact factor: 4.029

Review 8.  Epidemiology of non-alcoholic fatty liver disease in China.

Authors:  Jian-Gao Fan; Geoffrey C Farrell
Journal:  J Hepatol       Date:  2008-11-06       Impact factor: 25.083

9.  Threshold for effects of vitamin D deficiency on glucose metabolism in obese female African-American adolescents.

Authors:  Ambika Ashraf; Jessica Alvarez; Karen Saenz; Barbara Gower; Kenneth McCormick; Frank Franklin
Journal:  J Clin Endocrinol Metab       Date:  2009-06-23       Impact factor: 5.958

10.  Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals.

Authors:  Ling Lu; Zhijie Yu; An Pan; Frank B Hu; Oscar H Franco; Huaixing Li; Xiaoying Li; Xilin Yang; Yan Chen; Xu Lin
Journal:  Diabetes Care       Date:  2009-04-14       Impact factor: 17.152

View more
  14 in total

1.  Association between vitamin D and non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: results from a meta-analysis.

Authors:  Xiang Wang; Weiping Li; Ying Zhang; Yang Yang; Guijun Qin
Journal:  Int J Clin Exp Med       Date:  2015-10-15

2.  Calcium and vitamin D3 combinations improve fatty liver disease through AMPK-independent mechanisms.

Authors:  Sara Shojaei Zarghani; Hamid Soraya; Mohammad Alizadeh
Journal:  Eur J Nutr       Date:  2016-12-17       Impact factor: 5.614

3.  Low vitamin D status is associated with advanced liver fibrosis in patients with nonalcoholic fatty liver disease.

Authors:  Bing-Bing Yang; Yuan-Hua Chen; Cheng Zhang; Chang-E Shi; Kai-Feng Hu; Ju Zhou; De-Xiang Xu; Xi Chen
Journal:  Endocrine       Date:  2016-10-31       Impact factor: 3.633

Review 4.  Nonalcoholic fatty liver disease and aging: epidemiology to management.

Authors:  Marco Bertolotti; Amedeo Lonardo; Chiara Mussi; Enrica Baldelli; Elisa Pellegrini; Stefano Ballestri; Dante Romagnoli; Paola Loria
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

5.  Serum vitamin D is associated with non-alcoholic fatty liver disease in Chinese males with normal weight and liver enzymes.

Authors:  Ya-ping Hao; Xiao-jing Ma; Yu-qi Luo; Jie Ni; Jian-xin Dou; Ya-qin Hu; Jia-an Zhu; Yu-qian Bao; Wei-ping Jia
Journal:  Acta Pharmacol Sin       Date:  2014-08-04       Impact factor: 6.150

6.  The association of vitamin D deficiency with non-alcoholic fatty liver disease.

Authors:  Metin Küçükazman; Naim Ata; Kürşat Dal; Abdullah Özgür Yeniova; Ayşe Kefeli; Sebahat Basyigit; Bora Aktas; Kadir Okhan Akin; Kadir Ağladıoğlu; Öznur Sarı Üre; Firdes Topal; Yaşar Nazligül; Esin Beyan; Derun Taner Ertugrul
Journal:  Clinics (Sao Paulo)       Date:  2014-08       Impact factor: 2.365

Review 7.  Can skin exposure to sunlight prevent liver inflammation?

Authors:  Shelley Gorman; Lucinda J Black; Martin Feelisch; Prue H Hart; Richard Weller
Journal:  Nutrients       Date:  2015-05-05       Impact factor: 5.717

8.  Effect of Vitamin D Supplementation on C-reactive Protein in Patients with Nonalcoholic Fatty Liver.

Authors:  Mahdi Foroughi; Zahra Maghsoudi; Reza Ghiasvand; Bijan Iraj; Gholamreza Askari
Journal:  Int J Prev Med       Date:  2014-08

9.  The serum vitamin D level is inversely correlated with nonalcoholic fatty liver disease.

Authors:  Goh Eun Chung; Donghee Kim; Min-Sun Kwak; Jong In Yang; Jeong Yoon Yim; Seon Hee Lim; Mustafa Itani
Journal:  Clin Mol Hepatol       Date:  2016-03-28

Review 10.  The Common Mechanisms of Sarcopenia and NAFLD.

Authors:  Yu Zhai; Qian Xiao
Journal:  Biomed Res Int       Date:  2017-12-13       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.